Promoter group members disclose pledged shares for FY26

Ownership Changes View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹382.65

prior close

₹377.70

announcement price

In-mkt

timing

Nifty Microcap 250market+0.2%-1.1% vs market

Pharmaceuticals peers, median of 165sector-0.0%-1.0% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.2

15m

-0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.2-1.1-0.0-1.0

Next day

+0.7+1.0-0.3+0.0+0.7

+0.9+0.7+0.3+0.4+0.5

-0.9+0.9-1.8+0.1-0.9

+1.6+0.2+1.5-0.4+2.0

+1.9-1.8+3.7-1.2+3.1

+3.9+1.4+2.5-0.1+4.0

15d

+7.9-0.6+8.5-1.4+9.4

+6.5+1.5+5.1-1.2+7.8

+11.8+4.5+7.2+0.9+10.9

+9.5+3.1+6.4+0.0+9.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Harshit M. Savla, a Promoter of Aarti Drugs, has filed an annual declaration under SEBI takeover regulations for FY ended March 31, 2026. Promoter group members Mirik Rajendra Gogri and Renil Rajendra Gogri have encumbered 6,41,814 and 5,97,957 shares respectively. No other encumbrances were made by promoters during the fiscal year.

Likely market impact

Routine annual disclosure of existing pledged promoter group shares; no fresh encumbrance activity reported beyond what is already on record.